| Keith Fredrick Clark, MD PHD | |
|
535 Nw 9th St, Suite 300, Oklahoma City, OK 73102-1070 | |
| (405) 272-6027 | |
| (405) 272-8315 |
| Full Name | Keith Fredrick Clark |
|---|---|
| Gender | Male |
| Speciality | Otolaryngology |
| Experience | 46 Years |
| Location | 535 Nw 9th St, Oklahoma City, Oklahoma |
| Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1376506642 | NPI | - | NPPES |
| 157107001 | Medicaid | AR | |
| 731461178005 | Other | TRICARE | |
| A0209Z | Other | PPO OKLAHOMA | |
| 100823600B | Medicaid | OK | |
| 2994975 | Other | AETNA US HEALTHCARE | |
| P00075512 | Other | RR MEDICARE |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207Y00000X | Otolaryngology | 14220 (Oklahoma) | Primary |
| Facility Name | Location | Facility Type |
|---|---|---|
| Ssm Health St Anthony Hospital - Oklahoma City | Oklahoma city, OK | Hospital |
| Ssm Health St Anthony Hospital - Shawnee | Shawnee, OK | Hospital |
| Purcell Municipal Hospital | Purcell, OK | Hospital |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Saint Medical Group, Llc | 7012914898 | 298 |
News Archive
Covaris Inc. today announced that it has signed a co-marketing agreement with Illumina, Inc. making Covaris DNA shearing technologies the recommended method of shearing with Illumina next-generation sequencing product lines, including HiSeq, HiScanSQ, and Genome Analyzer.
Research may help physicians give patients undergoing total knee arthroplasty a realistic expectation of surgery outcome based on their overall physical and mental health, US researchers believe.
A team of researchers the University of Zurich and the University Hospital Zurich has shown that in multiple sclerosis, it is not only specific T cells that cause inflammation and lesions in the brain.
Evotec AG today announced that a compound in its strategic alliance with Boehringer Ingelheim has advanced into clinical trials. With the initiation of the Phase I clinical studies for this compound, Evotec will receive a milestone payment of EUR 2.0 million.
› Verified 1 days ago
| Entity Name | Saint Medical Group, Llc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1437195922 PECOS PAC ID: 7012914898 Enrollment ID: O20061109000189 |
News Archive
Covaris Inc. today announced that it has signed a co-marketing agreement with Illumina, Inc. making Covaris DNA shearing technologies the recommended method of shearing with Illumina next-generation sequencing product lines, including HiSeq, HiScanSQ, and Genome Analyzer.
Research may help physicians give patients undergoing total knee arthroplasty a realistic expectation of surgery outcome based on their overall physical and mental health, US researchers believe.
A team of researchers the University of Zurich and the University Hospital Zurich has shown that in multiple sclerosis, it is not only specific T cells that cause inflammation and lesions in the brain.
Evotec AG today announced that a compound in its strategic alliance with Boehringer Ingelheim has advanced into clinical trials. With the initiation of the Phase I clinical studies for this compound, Evotec will receive a milestone payment of EUR 2.0 million.
› Verified 1 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Keith Fredrick Clark, MD PHD 535 Nw 9th St, Suite 300, Oklahoma City, OK 73102-1070 Ph: (405) 272-6027 | Keith Fredrick Clark, MD PHD 535 Nw 9th St, Suite 300, Oklahoma City, OK 73102-1070 Ph: (405) 272-6027 |
News Archive
Covaris Inc. today announced that it has signed a co-marketing agreement with Illumina, Inc. making Covaris DNA shearing technologies the recommended method of shearing with Illumina next-generation sequencing product lines, including HiSeq, HiScanSQ, and Genome Analyzer.
Research may help physicians give patients undergoing total knee arthroplasty a realistic expectation of surgery outcome based on their overall physical and mental health, US researchers believe.
A team of researchers the University of Zurich and the University Hospital Zurich has shown that in multiple sclerosis, it is not only specific T cells that cause inflammation and lesions in the brain.
Evotec AG today announced that a compound in its strategic alliance with Boehringer Ingelheim has advanced into clinical trials. With the initiation of the Phase I clinical studies for this compound, Evotec will receive a milestone payment of EUR 2.0 million.
› Verified 1 days ago
Richard D. Kopke, M.D. Otolaryngology Medicare: Medicare Enrolled Practice Location: 3400 Nw 56th St, Oklahoma City, OK 73112 Phone: 405-946-5563 Fax: 405-947-6226 | |
Dr. Elena Beth Woodson, M.D. Otolaryngology Medicare: Not Enrolled in Medicare Practice Location: 9900 Broadway Ext Ste 200, Oklahoma City, OK 73114 Phone: 405-608-8833 Fax: 405-608-8818 | |
Dr. John R Houck Jr., MD Otolaryngology Medicare: Not Enrolled in Medicare Practice Location: 921 Ne 13th Street, Department Of Surgery, Oklahoma City, OK 73104 Phone: 405-456-3409 Fax: 405-456-5952 | |
Chelsey Smith, MD Otolaryngology Medicare: Accepting Medicare Assignments Practice Location: 920 Sl Young Blvd, Wp 1290, Oklahoma City, OK 73104 Phone: 405-271-5504 | |
Jesus E Medina, MD Otolaryngology Medicare: Medicare Enrolled Practice Location: 825 Ne 10th St # 4200, Oklahoma City, OK 73104 Phone: 405-271-7559 | |
Jimmy Argo, MD Otolaryngology Medicare: Accepting Medicare Assignments Practice Location: 920 Sl Young Blvd, Oklahoma City, OK 73104 Phone: 405-271-5504 | |
Adam Johnson, MD Otolaryngology Medicare: Medicare Enrolled Practice Location: 920 Sl Young Blvd, Wp 1290, Oklahoma City, OK 73104 Phone: 405-271-5504 |